Zimbabwe has turned down a significant US health deal worth 367 million US dollars (272 million pounds) over five years over the United States' demand for sensitive data.
This rejection became public after a internal memorandum dated December was disclosed, indicating that President Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government spokesman has since clarified that the US was demanding access to biological samples for research and commercial gain but was not willing to guarantee the benefits from any future medical innovations.
"We must now begin the difficult and regrettable task of ending our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had furnished over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has urged continued negotiations to secure a deal suitable to both sides so the country's critical HIV programme can proceed.
Broader Implications
This rejection comes after a similar case in neighbouring Kenya, where a high court halted a similar deal with the US following legal challenges were filed about the safety of citizens' medical information.
After returning to office recently, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had overseen aid for the American government, but Trump claimed its expenditure was "wasteful" and his government was seeking government-to-government agreements to enhance transparency and responsibility.
As per statements, 16 African countries have to date agreed to these new agreements, representing over $18.3bn in new funding.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership might have yielded significant advantages for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy via US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to surrender its genetic material and health information over an extended period, without any corresponding promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.
"Effectively, our nation would provide the basic resources for medical research without any certainty that the end products would be available to our citizens if a new pandemic emerge."
National Interest and International Frameworks
He also noted that the American exit from the global health body and its pursuit of bilateral health agreements were upending frameworks previously established through the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to manage potential pandemics.
"This mechanism is designed to ensure that when a nation provides its information, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the funds to create them."
The government's concerns over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to continued discussions with our American counterparts on how subsequent collaboration might be arranged in a manner that respects the independence and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but recommended that negotiations need to persist given that a large portion of the nation's Aids initiatives relied on external financing.
"Where specific concerns exist, such as those relating to information security or implementation frameworks, these can often be addressed via detailed discussion and negotiated safeguards," the group added.
This impasse emphasises the complex challenges between accepting much-needed international aid and safeguarding local interests in an increasingly interconnected world.